Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan;21(1):e14343.
doi: 10.1002/alz.14343. Epub 2024 Dec 22.

Sex and APOE ε4 allele differences in longitudinal white matter microstructure in multiple cohorts of aging and Alzheimer's disease

Affiliations

Sex and APOE ε4 allele differences in longitudinal white matter microstructure in multiple cohorts of aging and Alzheimer's disease

Amalia Peterson et al. Alzheimers Dement. 2025 Jan.

Abstract

Introduction: The effects of sex and apolipoprotein E (APOE)-Alzheimer's disease (AD) risk factors-on white matter microstructure are not well characterized.

Methods: Diffusion magnetic resonance imaging data from nine well-established longitudinal cohorts of aging were free water (FW)-corrected and harmonized. This dataset included 4741 participants (age = 73.06 ± 9.75) with 9671 imaging sessions over time. FW and FW-corrected fractional anisotropy (FAFWcorr) were used to assess differences in white matter microstructure by sex and APOE ε4 carrier status.

Results: Sex differences in FAFWcorr in projection tracts and APOE ε4 differences in FW limbic and occipital transcallosal tracts were most pronounced.

Discussion: There are prominent differences in white matter microstructure by sex and APOE ε4 carrier status. This work adds to our understanding of disparities in AD. Additional work to understand the etiology of these differences is warranted.

Highlights: Sex and apolipoprotein E (APOE) ε4 carrier status relate to white matter microstructural integrity. Females generally have lower free water-corrected fractional anisotropy compared to males. APOE ε4 carriers tended to have higher free water than non-carriers.

Keywords: Alzheimer's disease; aging; sex differences; white matter disease.

PubMed Disclaimer

Conflict of interest statement

S.C.J. has served on advisory boards for Enigma Biomedical and ALZPath in the past 2 years. A.J.S. receives support from multiple NIH grants (P30 AG010133, P30 AG072976, R01 AG019771, R01 AG057739, U19 AG024904, R01 LM013463, R01 AG068193, T32 AG071444, U01 AG068057, U01 AG072177, U19 AG074879, and U24 AG074855). He has also received support from Avid Radiopharmaceuticals, a subsidiary of Eli Lilly (in kind contribution of PET tracer precursor) and participated in scientific advisory boards (Bayer Oncology, Eisai, Novo Nordisk, and Siemens Medical Solutions USA, Inc) and an observational study monitoring board (MESA, NIH NHLBI), as well as external advisory committees for multiple NIA grants. He also serves as editor in chief of Brain Imaging and Behavior, a Springer‐Nature journal. B.A.L. serves as editor in chief of SPIE Journal of Medical Imaging. L.L.B. serves as deputy editor of Alzheimer's & Dementia. A.L.J. serves on the NINDS DIVERSE VCID and NINDS RECOVERY observational study monitoring boards. She serves on the scientific advisory committee for the Paul B. Beeson Emerging Leaders Career Development Program, American Federation for Aging Research. She serves on the Clin‐STAR Coordinating Center External Advisory Committee, the external advisory board for the Kansas Alzheimer's Disease Core Center, and the Alzheimer's Disease and Related Dementia Advisory Council. A.W.T. serves on the RHU‐SHIVA data safety monitoring board and the ADNI Steering Committee and Executive Committee and is a member of the World Dementia Council and the Alzheimer's Disease Initiative Global Technical Advisory Committee. T.J.H. serves on the scientific advisory board for Vivid Genomics. He serves as Alzheimer's & Dementia: TRCI deputy editor and the Alzheimer's & Dementia senior associate editor. J.E.W. received financial support from IONIS pharmaceuticals. A.P., A.S., D.Z., Y.Y., A.D., K.D.D., N.S., K.R.P., M.E.K., C.G., N.M.K., Z.L., T.Y., Y.K., L.D., K.A.G., F.E.C., S.L.R., L.L.B.H., Y.A., K.A., G.E., C.D., D.T., P.M.T., E.C.M., M.H., D.W., P.Z., K.S., M.A., W.K., S.A.B., J.S., D.A.B., S.M.R., D.B.A., ADNI, BIOCARD, and ADSP have no conflicts to disclose. The authors declare no conflicts of interest. Author disclosures are available in the supporting information.

Figures

FIGURE 1
FIGURE 1
Forty‐eight white matter tractography templates were used in the present study, and can be grouped into TC (A), association (B), projection (C), and limbic tracts (D). IFG, inferior frontal gyrus; IFOF, inferior fronto‐occipital fasciculus; ILF, inferior longitudinal fasciculus; IPL, inferior parietal lobe; M1, primary motor cortex; PMd, dorsal premotor; PMv, ventral premotor; S1, primary somatosensory cortex; SLF, superior longitudinal fasciculus; SLF‐TP, temporoparietal superior longitudinal fasciculus; SMA, supplementary motor area; SPL, superior parietal lobe; TC, transcallosal; UF, uncinate fasciculus.
FIGURE 2
FIGURE 2
The main effects of sex and APOE ε4 on change in white matter microstructure. Linear mixed effects regression was conducted to determine the association of sex and APOE ε4 positivity on change in FAFWcorr (A) and change in FW (B). For both measures, heatmaps are grouped by tract type and illustrate the test statistic (i.e., z value) for each independent regression analysis. The top sex and APOE ε4 associations for both measures are illustrated with spaghetti plots. *Tracts surviving correction for multiple comparisons. APOE, apolipoprotein E; CC, corpus callosum; FAFWcorr, free water‐corrected fractional anisotropy; FW, free water; IFG, inferior frontal gyrus; IFOF, inferior fronto‐occipital fasciculus; ILF, inferior longitudinal fasciculus; IPL, inferior parietal lobe; M1, primary motor cortex; PMd, dorsal premotor; PMv, ventral premotor; S1, primary somatosensory cortex; SLF, superior longitudinal fasciculus; SLF‐TP, temporoparietal superior longitudinal fasciculus; SMA, supplementary motor area; SPL, superior parietal lobe; TC, transcallosal; UF, uncinate fasciculus.
FIGURE 3
FIGURE 3
Aggregated tract‐type associations with changes in white matter microstructure. z values of individual tracts were grouped into the following tract types: association, limbic, projection, prefrontal TC, motor TC, parietal TC, and occipital TC for FAFWcorr (A) and FW (B). The left, middle, and right columns display the sex main effect (red), APOE ε4 main effect (blue), and sex × APOE ε4 interaction (orange), respectively. APOE, apolipoprotein E; FAFWcorr, free water–corrected fractional anisotropy; FW, free water; TC, transcallosal.

Update of

Similar articles

  • White Matter Abnormalities and Cognition in Aging and Alzheimer Disease.
    Peter C, Sathe A, Shashikumar N, Pechman KR, Workmeister AW, Jackson TB, Huo Y, Mukherjee S, Mez J, Dumitrescu LC, Gifford KA, Bolton CJ, Gaynor LS, Risacher SL, Beason-Held LL, An Y, Arfanakis K, Erus G, Davatzikos C, Tosun-Turgut D, Habes M, Wang D, Toga AW, Thompson PM, Zhang P, Schilling KG, Albert M, Kukull W, Biber SA, Landman BA, Bendlin BB, Johnson SC, Schneider J, Barnes LL, Bennett DA, Jefferson AL, Resnick SM, Saykin AJ, Crane PK, Cuccaro ML, Hohman TJ, Archer DB; and the Alzheimer’s Disease Sequencing Project Phenotype Harmonization Consortium (ADSP-PHC) Analyst Team; Zaras D, Yang Y, Durant A, Kanakaraj P, Kim ME, Gao C, Newlin NR, Ramadass K, Khairi NM, Li Z, Yao T, Choi SE, Klinedinst B, Lee ML, Scollard P, Trittschuh EH, Sanders EA. Peter C, et al. JAMA Neurol. 2025 Aug;82(8):825-836. doi: 10.1001/jamaneurol.2025.1601. Epub 2025 Jun 9. JAMA Neurol. 2025. PMID: 40513084 Free PMC article.
  • Sex, racial, and APOE-ε4 allele differences in longitudinal white matter microstructure in multiple cohorts of aging and Alzheimer's disease.
    Peterson A, Sathe A, Zaras D, Yang Y, Durant A, Deters KD, Shashikumar N, Pechman KR, Kim ME, Gao C, Khairi NM, Li Z, Yao T, Huo Y, Dumitrescu L, Gifford KA, Wilson JE, Cambronero F, Risacher SL, Beason-Held LL, An Y, Arfanakis K, Erus G, Davatzikos C, Tosun D, Toga AW, Thompson PM, Mormino EC, Zhang P, Schilling K; Alzheimer’s Disease Neuroimaging Initiative (ADNI); BIOCARD Study Team; Alzheimer’s Disease Sequencing Project (ADSP); Albert M, Kukull W, Biber SA, Landman BA, Johnson SC, Schneider J, Barnes LL, Bennett DA, Jefferson AL, Resnick SM, Saykin AJ, Hohman TJ, Archer DB. Peterson A, et al. bioRxiv [Preprint]. 2024 Jun 12:2024.06.10.598357. doi: 10.1101/2024.06.10.598357. bioRxiv. 2024. Update in: Alzheimers Dement. 2025 Jan;21(1):e14343. doi: 10.1002/alz.14343. PMID: 38915636 Free PMC article. Updated. Preprint.
  • Associations between APOE-TOMM40 '523 haplotypes and limbic system white matter microstructure.
    Mooney KE, Archer DB, Sathe A, Hohman TJ, Kadiri O, Lamar M, Arfanakis K, Yu L, Barnes LL, Deters KD. Mooney KE, et al. Alzheimers Dement (Amst). 2025 Apr 6;17(2):e70099. doi: 10.1002/dad2.70099. eCollection 2025 Apr-Jun. Alzheimers Dement (Amst). 2025. PMID: 40201595 Free PMC article.
  • Sex and APOE ε4 carrier effects on atrophy, amyloid PET, and tau PET burden in early-onset Alzheimer's disease.
    Nemes S, Logan PE, Manchella MK, Mundada NS, La Joie R, Polsinelli AJ, Hammers DB, Koeppe RA, Foroud TM, Nudelman KN, Eloyan A, Iaccarino L, Dorsant-Ardón V, Taurone A, Thangarajah M, Dage JL, Aisen P, Grinberg LT, Jack CR Jr, Kramer J, Kukull WA, Murray ME, Rumbaugh M, Soleimani-Meigooni DN, Toga A, Touroutoglou A, Vemuri P, Atri A, Day GS, Duara R, Graff-Radford NR, Honig LS, Jones DT, Masdeu J, Mendez MF, Musiek E, Onyike CU, Riddle M, Rogalski E, Salloway S, Sha SJ, Turner RS, Wingo TS, Womack KB, Wolk DA, Rabinovici GD, Carrillo MC, Dickerson BC, Apostolova LG; LEADS Consortium. Nemes S, et al. Alzheimers Dement. 2023 Nov;19 Suppl 9(Suppl 9):S49-S63. doi: 10.1002/alz.13403. Epub 2023 Jul 26. Alzheimers Dement. 2023. PMID: 37496307 Free PMC article.
  • APOE ε4 and Dietary Patterns in Relation to Cognitive Function: An Umbrella Review of Systematic Reviews.
    Urich TJ, Tsiknia AA, Ali N, Park J, Mack WJ, Cortessis VK, Dinalo JE, Yassine HN. Urich TJ, et al. Nutr Rev. 2025 Jul 1;83(7):e2113-e2126. doi: 10.1093/nutrit/nuae156. Nutr Rev. 2025. PMID: 39499795

Cited by

  • The effect of Alzheimer's disease genetic factors on limbic white matter microstructure.
    Lorenz A, Sathe A, Zaras D, Yang Y, Durant A, Kim ME, Gao C, Newlin NR, Ramadass K, Kanakaraj P, Khairi NM, Li Z, Yao T, Huo Y, Dumitrescu L, Shashikumar N, Pechman KR, Jackson TB, Workmeister AW, Risacher SL, Beason-Held LL, An Y, Arfanakis K, Erus G, Davatzikos C, Habes M, Wang D, Tosun D, Toga AW, Thompson PM, Mormino EC, Zhang P, Schilling K; Alzheimer's Disease Neuroimaging Initiative (ADNI)The BIOCARD Study TeamThe Alzheimer's Disease Sequencing Project (ADSP); Albert M, Kukull W, Biber SA, Landman BA, Johnson SC, Bendlin B, Schneider J, Barnes LL, Bennett DA, Jefferson AL, Resnick SM, Saykin AJ, Hohman TJ, Archer DB. Lorenz A, et al. Alzheimers Dement. 2025 Apr;21(4):e70130. doi: 10.1002/alz.70130. Alzheimers Dement. 2025. PMID: 40219815 Free PMC article.
  • White Matter Abnormalities and Cognition in Aging and Alzheimer Disease.
    Peter C, Sathe A, Shashikumar N, Pechman KR, Workmeister AW, Jackson TB, Huo Y, Mukherjee S, Mez J, Dumitrescu LC, Gifford KA, Bolton CJ, Gaynor LS, Risacher SL, Beason-Held LL, An Y, Arfanakis K, Erus G, Davatzikos C, Tosun-Turgut D, Habes M, Wang D, Toga AW, Thompson PM, Zhang P, Schilling KG, Albert M, Kukull W, Biber SA, Landman BA, Bendlin BB, Johnson SC, Schneider J, Barnes LL, Bennett DA, Jefferson AL, Resnick SM, Saykin AJ, Crane PK, Cuccaro ML, Hohman TJ, Archer DB; and the Alzheimer’s Disease Sequencing Project Phenotype Harmonization Consortium (ADSP-PHC) Analyst Team; Zaras D, Yang Y, Durant A, Kanakaraj P, Kim ME, Gao C, Newlin NR, Ramadass K, Khairi NM, Li Z, Yao T, Choi SE, Klinedinst B, Lee ML, Scollard P, Trittschuh EH, Sanders EA. Peter C, et al. JAMA Neurol. 2025 Aug;82(8):825-836. doi: 10.1001/jamaneurol.2025.1601. Epub 2025 Jun 9. JAMA Neurol. 2025. PMID: 40513084 Free PMC article.
  • Longitudinal effects of sex differences and apolipoprotein E genotype on white matter engagement among elderly.
    Zhang H, Zhang J, Hsu CL, Hui ES, Tse KH, Mak HK, Shum DHK. Zhang H, et al. Brain Commun. 2025 Jul 17;7(4):fcaf278. doi: 10.1093/braincomms/fcaf278. eCollection 2025. Brain Commun. 2025. PMID: 40740432 Free PMC article.
  • Cerebrospinal fluid YKL-40 relates to white matter hyperintensity progression in females but not males over a 6-year period.
    Peterson AJ, Sun Y, Archer DB, Adegboye HA, Moore EE, Deberghes I, Pechman KR, Shashikumar N, Robb WH, Workmeister AW, Jackson TB, Liu D, Dumitrescu L, Davis LT, Landman BA, Blennow K, Zetterberg H, Hohman TJ, Jefferson AL. Peterson AJ, et al. Alzheimers Dement (Amst). 2025 May 9;17(2):e70110. doi: 10.1002/dad2.70110. eCollection 2025 Apr-Jun. Alzheimers Dement (Amst). 2025. PMID: 40352684 Free PMC article.
  • Longitudinal tract-based spatial statistics analysis of white matter diffusivity changes and cognitive decline during the transition from MCI to Alzheimer's disease.
    Lim S, Kim H, Lee Y; Alzheimer’s Disease Neuroimaging Initiative. Lim S, et al. PLoS One. 2025 Aug 5;20(8):e0329893. doi: 10.1371/journal.pone.0329893. eCollection 2025. PLoS One. 2025. PMID: 40763286 Free PMC article.

References

    1. Sachdev PS, Zhuang L, Braidy N, Wen W. Is Alzheimer's a disease of the white matter?. Curr Opin Psychiatry. 2013;26:244‐251. - PubMed
    1. Ihara M, Polvikoski TM, Hall R, et al. Quantification of myelin loss in frontal lobe white matter in vascular dementia, Alzheimer's disease, and dementia with lewy bodies. Acta Neuropathol. 2010;119:579‐589. - PMC - PubMed
    1. Simpson JE, Ince PG, Higham CE, et al. Microglial activation in white matter lesions and nonlesional white matter of ageing brains. Neuropathol Appl Neurobiol. 2007;33:670‐683. - PubMed
    1. Lee S, Viqar F, Zimmerman ME, et al. White matter hyperintensities are a core feature of Alzheimer's disease: evidence from the dominantly inherited Alzheimer network. Ann Neurol. 2016;79:929‐939. - PMC - PubMed
    1. Bateman RJ, Xiong C, Benzinger TL, et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med. 2012;367:795‐804. - PMC - PubMed

MeSH terms

Substances

Grants and funding